With the sp on retreat and positive announcements not forthcoming I thought that I would spice things up a little with a "what if".
What if the reason for the delay in submitting the IND is because a big pharma is the third party that we are waiting for? What if, they want to be part of the trial but have needed time to prepare their info for the FDA because they have had no involvement to-date with TT-034 and so would need time to define their contribution?
Enter Novartis!!!
BLT Price at posting:
50.0¢ Sentiment: Buy Disclosure: Held